Medicine & Life Sciences
Visceral Leishmaniasis
92%
DNA Vaccines
91%
Parasites
62%
Dogs
54%
Canidae
43%
Vaccination
40%
Leishmania infantum
34%
Antigens
31%
Leishmania
29%
Delayed Hypersensitivity
28%
Granulocyte-Macrophage Colony-Stimulating Factor
26%
Interleukin-12
25%
Cellular Immunity
24%
Interleukin-4
23%
Lymph Nodes
17%
DNA
13%
Skin
13%
Growth
12%
Incidence
12%
Infections
11%
In Vitro Techniques
10%
Agriculture & Biology
recombinant vaccines
100%
visceral leishmaniasis
98%
immunogenicity
89%
dogs
57%
parasites
30%
vaccination
27%
antigens
22%
interleukin-12
20%
Leishmania donovani
19%
delayed hypersensitivity
18%
promastigotes
18%
interleukin-4
18%
Leishmania
17%
cell-mediated immunity
16%
adjuvants
15%
lymph nodes
15%
incidence
10%
infection
7%
DNA
7%
Social Sciences
vaccination
83%
incidence
31%